Opus Genetics, Inc. (FRA:R3X1)

Germany · Delayed Price · Currency is EUR

1.706

-0.096 (-5.33%)

At close: Dec 1, 2025

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2001 - 2009
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '10 Dec 31, 2010	2001 - 2009
Vision Performance and Health	10.99M	Log In	Log In	Log In	Log In	Upgrade
Vision Performance and Health Growth	-42.30%	Log In	Log In	Log In	Log In	Upgrade
Innovative Treatments	-	Log In	Log In	Log In	Log In	Upgrade
Innovative Treatments Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2001 - 2009
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '10 Dec 31, 2010	2001 - 2009
United States	10.99M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-42.30%	Log In	Log In	Log In	Log In	Upgrade